EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 8-Jul-2025 18:10 ET (8-Jul-2025 22:10 GMT/UTC)

New immune-probing technique could boost treatment discovery

The University of Osaka
Peer-Reviewed Publication

A team from Osaka University has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously control the immune system. The team identified key immune cells controlled by Tregs and found that Tregs are targets for the cancer drugs ipilimumab and tazemetostat. They also found that Tregs are indicators of serious viral infection. This valuable technique may accelerate the development of treatments for cancer and other diseases.

Journal: Nature Communications
Funder: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, The Nippon Foundation - Osaka University Project for Infectious Disease Prevention, IFReC advanced postdoc program, IFReC grant program for next generation principal investigators, Takeda Foundation, Leading Advanced Projects for Medical Innovation

Innovative dual-target drug may lead to new investigational approach for breast cancer patients

University of Melbourne
Peer-Reviewed Publication

Researchers discover new insights into how dual-target drug may supercharge cancer-fighting immune cells.

Journal: Clinical & Translational Immunology
Funder: National Health and Medical Research Council, Pfizer

AI unlocks genetic clues to personalize cancer treatment

University of Southern California
Peer-Reviewed Publication

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes—insights that could help doctors tailor treatments more effectively. The largest study of its kind, the research analyzed data for more than 78,000 cancer patients across 20 cancer types. Patients received immunotherapies, chemotherapies and targeted therapies.

Journal: Nature Communications

Anti-smoking program adds wastewater-based epidemiology to track nicotine use in communities

University of California - Merced
Grant and Award Announcement

University of California, Merced's Nicotine and Cannabis Policy Center has embarked on an innovative partnership with researchers at the university who track an entire community’s health and habits with samples of human sewage.

Funder: Tobacco-Related Disease Research Program

Breast cancer treatment advances with light-activated ‘smart bomb’

University of California - Riverside
Peer-Reviewed Publication

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated metastatic breast cancer tumors.

Journal: Angewandte Chemie

Short-course radiation therapy effective for endometrial cancer patients

Huntsman Cancer Institute
Peer-Reviewed Publication

Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

Journal: JCO Oncology Advances

Cancer’s ripple effect may promote blood clot formation in the lungs

Weill Cornell Medicine
Peer-Reviewed Publication

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and University of California San Diego Health. Clots are the second-leading cause of death among cancer patients with advanced disease or aggressive tumors.

Journal: Cell

PING

University of Texas at Austin
Book Announcement

We’ve all been there—sitting through a meeting that could’ve easily been an email. And that email? Maybe it should have been a quick voice note. And your camera? It’s okay to turn it off. In fact, sometimes it’s even better.

Andrew Brodsky—a Harvard Business School doctoral graduate, award-winning business professor, management consultant, and expert in virtual communication at The University of Texas at Austin—has dedicated his career to unraveling the intricacies of virtual communication. Diagnosed with cancer as a teenager, his treatment led to a lifelong immune deficiency, which has resulted in years of his life being confined primarily to the virtual realm. This personal experience has given him a unique understanding of the challenges and nuances of communicating from a distance.

New perspectives for personalized therapy of brain tumors

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as closely as possible. Drug tests in this model were found to correlate very well with actual patient responses, making it a valuable method for investigating therapies.

Journal: Cell Stem Cell

Dana-Farber researchers present findings at 2025 ASCO Genitourinary Cancers Symposium

Dana-Farber Cancer Institute
Reports and Proceedings

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025, in San Francisco, Calif. The Dana-Farber led research exemplifies innovative and multidisciplinary expertise in prostate, kidney, and bladder cancers, and includes studies examining novel treatments and predictive biomarkers.

Meeting: ASCO Genitourinary (GU) Cancers Symposium